Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice

被引：15
作者：
Baz, Mariana
Abed, Yacine
Nehme, Benjamin
Boivin, Guy [1 ]
机构：
[1] CHUL, CHUQ, Res Ctr Infect Dis, Ste Foy, PQ G1V 4G2, Canada
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 02期
关键词：
A-315675; INFECTION;
D O I：
10.1128/AAC.01276-08
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The new oral neuraminidase (NA) inhibitor A-322278 was evaluated in mice infected with influenza A/H1N1 wild-type virus or the oseltamivir-resistant (H274Y mutant) virus. A-322278 decreased mortality rates and lung virus titers significantly more than oseltamivir in mice infected with the NA H274Y mutant when therapy was started 4 h before or even 48 h after infection.
引用
收藏
页码：791 / 793
页数：3
相关论文
共 50 条
  • [41] Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites
    Maurer-Stroh, Sebastian
    Ma, Jianmin
    Lee, Raphael Tze Chuen
    Sirota, Fernanda L.
    Eisenhaber, Frank
    BIOLOGY DIRECT, 2009, 4
  • [42] Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase
    Jiang, Lianlian
    Fantoni, Giovanna
    Couzens, Laura
    Gao, Jin
    Plant, Ewan
    Ye, Zhiping
    Eichelberger, Maryna C.
    Wan, Hongquan
    JOURNAL OF VIROLOGY, 2016, 90 (01) : 117 - 128
  • [43] DNA-Epitope Vaccine Provided Efficient Protection to Mice Against Lethal Dose of Influenza A Virus H1N1
    Wei, Huiling
    Lenz, Stephen D.
    Thompson, David H.
    Pogranichniy, Roman M.
    VIRAL IMMUNOLOGY, 2014, 27 (01) : 14 - 19
  • [44] Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus
    Skountzou, Ioanna
    Koutsonanos, Dimitrios G.
    Kim, Jin Hyang
    Powers, Ryan
    Satyabhama, Lakshmipriyadarshini
    Masseoud, Feda
    Weldon, William C.
    Martin, Maria del Pilar
    Mittler, Robert S.
    Compans, Richard
    Jacob, Joshy
    JOURNAL OF IMMUNOLOGY, 2010, 185 (03) : 1642 - 1649
  • [45] Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days
    Ryoo, Seung M.
    Kim, Won Y.
    Sohn, Chang H.
    Seo, Dong W.
    Oh, Bum J.
    Lee, Jae H.
    Lee, Yoon S.
    Lim, Kyoung S.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (05) : 833 - 837
  • [46] Susceptibility of Highly Pathogenic H5N1 Influenza Viruses to the Neuraminidase Inhibitor Oseltamivir Differs In Vitro and in a Mouse Model
    Govorkova, Elena A.
    Ilyushina, Natalia A.
    McClaren, Jennifer L.
    Naipospos, Tri S. P.
    Douangngeun, Bounlom
    Webster, Robert G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 3088 - 3096
  • [47] Strain-Specific Antagonism of the Human H1N1 Influenza A Virus against Equine Tetherin
    Wang, Meiyue
    Zhang, Zhenyu
    Wang, Xiaojun
    VIRUSES-BASEL, 2018, 10 (05):
  • [48] Effectiveness of Seasonal Influenza Vaccine against Pandemic (H1N1) 2009 Virus, Australia, 2010
    Fielding, James E.
    Grant, Kristina A.
    Garcia, Katherine
    Kelly, Heath A.
    EMERGING INFECTIOUS DISEASES, 2011, 17 (07) : 1181 - 1187
  • [49] Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs
    Xu, Jiarong
    Huang, Dongyan
    Liu, Shichao
    Lin, Huixing
    Zhu, Haodan
    Liu, Bao
    Lu, Chengping
    VACCINE, 2012, 30 (20) : 3119 - 3125
  • [50] Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice
    Fang, Jing
    Chen, Zhihui
    Liu, Xiaoqing
    Li, Huaifang
    Wang, Jianjun
    Shen, Xiaona
    Chen, Wei
    Liu, Yuan
    Wang, Yue
    Zhao, Ping
    Qi, Zhongtian
    JOURNAL OF VIROLOGICAL METHODS, 2011, 173 (02) : 314 - 319
12345